EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Release of substance P from the cat spinal cord



Release of substance P from the cat spinal cord



Journal of Physiology 391: 141-167



1. The present experiments examine the physiology and pharmacology of the release of substance P-like immunoreactivity (SP-l.i.), from the spinal cord in the halothane-anaesthetized, artificially ventilated cat. 2. Resting release of SP-l.i. was 36 +/- 4 fmol/30 min (mean +/- S.E.; n = 106). Bilateral stimulation of the sciatic nerves at intensities which evoked activity in fibres conducting at A beta conduction velocities (greater than 40 m/s), resulted in no change in blood pressure, pupil diameter or release of SP-l.i. Stimulation intensities which activate fibres conducting at velocities less than 2 m/s resulted in increased blood pressure, miosis and elevated release of SP-l.i. (278 +/- 16% of control). 3. The relationship between nerve-stimulation frequency and release was monotonic up to approximately 20 Hz. Higher stimulation frequencies did not increase the amounts of SP-l.i. released. At 200 Hz there was a reduction. 4. Capsaicin (0.1 mM) increased the release of SP-l.i. from the spinal cord and resulted in an acute desensitization to subsequent nerve stimulation. This acute effect was not accompanied by a reduction in spinal levels of SP-l.i. measured 2 h after stimulation. 5. Cold block of the cervical spinal cord resulted in an increase in the amounts of SP-l.i. released by nerve stimulation. 6. Pre-treatment with intrathecal 5,6-dihydroxytryptamine (300 micrograms) 7 days prior to the experiment caused a reduction in the dorsal and ventral horn stores of SP-l.i., but had no effect on the release of SP-l.i. evoked by nerve stimulation. Similar pre-treatment with intrathecal capsaicin (300 micrograms) resulted in depletion of SP-l.i. in the dorsal but not in the ventral horn of the spinal cord and diminished the release of SP-l.i. evoked by nerve stimulation. 7. Intense thermal stimulation of the flank resulted in small (20-35%), but reliable increases in the release of SP-l.i. above control. 8. Putative agonists for the opioid mu-receptor (morphine, 10-100 microM; sufentanil, 1 microM), and for the delta-receptor (D-Ala2-D-Leu5-enkephalin, 1-10 microM; D-Pen2-D-Pen5-enkephalin, 10 microM), but not the kappa-receptor (U50488H, 100-1000 microM), produced a dose-dependent, naloxone-reversible reduction of the evoked, but not of the resting release of SP-l.i. (-)-Naloxone, but not (+)-naloxone, resulted in a significant increase in evoked but not resting SP-l.i. release.(ABSTRACT TRUNCATED AT 400 WORDS)

(PDF same-day service: $19.90)

Accession: 006306474

Download citation: RISBibTeXText

PMID: 2451003

DOI: 10.1113/jphysiol.1987.sp016731



Related references

Modulation of cardiac ischemia-sensitive afferent neuron signaling by preemptive C2 spinal cord stimulation: effect on substance P release from rat spinal cord. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 294(1): R93-101, 2007

Release of substance p in the dorsal lumbar spinal cord of the conscious freely moving rat effects of kainic acid capsaicin and substance p1 7. Society for Neuroscience Abstracts 16(1): 161, 1990

Spinal nerve lesion-induced changes in substance P release from rat spinal cord. Society for Neuroscience Abstracts 25(1-2): 681, 1999

Left vagal stimulation induces dynorphin release and suppresses substance P release from the rat thoracic spinal cord during cardiac ischemia. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 287(6): R1468-R1477, 2004

Substance P release from rat hypothalamus and spinal cord. South African Medical Journal 57(20): 827-830, 1980

Morphine and substance P release in the spinal cord. Experimental Brain Research 82(1): 89-96, 1990

Substance P release from spinal cord slices by capsaicin. Life Sciences 25(7): 629-636, 1979

Effect of neurotrophin 3 on the release of substance P from the rat spinal cord. British Journal of Pharmacology 120(PROC SUPPL ): 70P, 1997

Effect of lamotrigine on glutamate and substance P release from the rat spinal cord. British Journal of Pharmacology 112(PROC SUPPL MAY): 11P, 1994

Evoked release of glutamate by substance p from newborn rat spinal cord. Journal of the Physiological Society of Japan 49(8-9): 381, 1987

Release of substance P-like immunoreactivity from isolated spinal cord of newborn rat. Nature 264(5581): 83-84, 1976

Sumatriptan inhibits the release of CGRP and substance P from the rat spinal cord. Neuroreport 7(12): 1973-1976, 1996

Frequency dependence of substance P release by electroacupuncture in rat spinal cord. Sheng Li Xue Bao 48(1): 89-93, 1996

Glutamate-stimulated ATP release from spinal cord astrocytes is potentiated by substance P. Journal of Neurochemistry 99(3): 924-936, 2006